WO1998018439A1 - Compositions for reducing body odors and excess moisture - Google Patents
Compositions for reducing body odors and excess moisture Download PDFInfo
- Publication number
- WO1998018439A1 WO1998018439A1 PCT/US1997/019262 US9719262W WO9818439A1 WO 1998018439 A1 WO1998018439 A1 WO 1998018439A1 US 9719262 W US9719262 W US 9719262W WO 9818439 A1 WO9818439 A1 WO 9818439A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- odor
- skin
- present
- cyclodextrin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 151
- 208000035985 Body Odor Diseases 0.000 title abstract description 27
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 54
- 239000000843 powder Substances 0.000 claims abstract description 41
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000006096 absorbing agent Substances 0.000 claims abstract description 20
- 239000010457 zeolite Substances 0.000 claims abstract description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000001166 anti-perspirative effect Effects 0.000 claims abstract description 11
- 239000003213 antiperspirant Substances 0.000 claims abstract description 11
- 239000004599 antimicrobial Substances 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 4
- 239000007921 spray Substances 0.000 claims description 23
- 239000002245 particle Substances 0.000 claims description 15
- -1 silicas Chemical class 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000000378 calcium silicate Substances 0.000 claims description 9
- 229910052918 calcium silicate Inorganic materials 0.000 claims description 9
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims description 9
- 239000003974 emollient agent Substances 0.000 claims description 9
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 7
- 239000001095 magnesium carbonate Substances 0.000 claims description 7
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 7
- 210000004197 pelvis Anatomy 0.000 claims description 7
- 210000001215 vagina Anatomy 0.000 claims description 7
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 6
- 206010046935 Vaginal odour Diseases 0.000 claims description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 6
- 230000001333 moisturizer Effects 0.000 claims description 6
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 5
- 150000004760 silicates Chemical class 0.000 claims description 5
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 claims description 2
- 239000011667 zinc carbonate Substances 0.000 claims description 2
- 235000004416 zinc carbonate Nutrition 0.000 claims description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 claims description 2
- 206010040904 Skin odour abnormal Diseases 0.000 abstract description 17
- 210000003491 skin Anatomy 0.000 description 63
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 61
- 235000019645 odor Nutrition 0.000 description 38
- 239000004615 ingredient Substances 0.000 description 21
- 239000000377 silicon dioxide Substances 0.000 description 21
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 18
- 229940008099 dimethicone Drugs 0.000 description 17
- 239000004205 dimethyl polysiloxane Substances 0.000 description 17
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 17
- 229960003500 triclosan Drugs 0.000 description 17
- 229920002472 Starch Polymers 0.000 description 16
- 235000019698 starch Nutrition 0.000 description 16
- 239000008107 starch Substances 0.000 description 16
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 14
- 229910021485 fumed silica Inorganic materials 0.000 description 14
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 13
- 239000004005 microsphere Substances 0.000 description 12
- 229920002261 Corn starch Polymers 0.000 description 11
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 239000008120 corn starch Substances 0.000 description 11
- 229940099112 cornstarch Drugs 0.000 description 11
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 11
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 11
- 229940097362 cyclodextrins Drugs 0.000 description 10
- 230000000699 topical effect Effects 0.000 description 10
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 10
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 10
- 235000012241 calcium silicate Nutrition 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 7
- 229920000299 Nylon 12 Polymers 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 239000011787 zinc oxide Substances 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 6
- 239000002480 mineral oil Substances 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 5
- 241001116389 Aloe Species 0.000 description 5
- 239000005995 Aluminium silicate Substances 0.000 description 5
- 239000001116 FEMA 4028 Substances 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 235000012211 aluminium silicate Nutrition 0.000 description 5
- 239000003908 antipruritic agent Substances 0.000 description 5
- 229960004853 betadex Drugs 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 239000002781 deodorant agent Substances 0.000 description 5
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229940052366 colloidal oatmeal Drugs 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- OVGXLJDWSLQDRT-CEOVSRFSSA-L magnesium;(2s)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O OVGXLJDWSLQDRT-CEOVSRFSSA-L 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 229960001296 zinc oxide Drugs 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 102100030350 Prolactin-inducible protein Human genes 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000000498 ball milling Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 2
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000003621 hammer milling Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940042472 mineral oil Drugs 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 1
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960000829 kaolin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229940098458 powder spray Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 230000008786 sensory perception of smell Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
Definitions
- Body odor is most commonly caused by fatty acids on skin and by malodors from microbial sources.
- the human skin is naturally populated with numerous micro-organisms which are nourished by various skin secreted substances (eccrine and apocrine sweat, and sebum), skin cell debris, breakdown products of the skin and the organisms themselves.
- These unpleasant body odors are mainly organic molecules which have different structures and functional groups, such as amines, acids, alcohols, aldehydes, ketones, phenolics, polycyclics, indoles, aromatics, polyaromatics, etc. They can also be made up of sulfur- containing functional groups, such as, thiol, mercaptan, sulf.de and/or disulfide groups.
- deodorant compositions aimed at combating controlling odor associated with skin secretions, which have been described in the chemical and cosmetic literature, include emulsion sticks or suspensoid sticks, aerosols, roll-ons, pads, pump sprays, and even soap bars. These known deodorants attempt to control odor through a variety of means. For instance, U.S. Patent No. 5,525,331, to Betts, issued June 11, 1996, discloses compositions which inhibit the growth of micro-organisms in the body-secretions. Deodorants may also include antibacterial compounds which help destroy/control the amount of bacteria present on skin, thereby minimising odor produced via bacterial metabolism of skin secretions.
- Zeolites are known odor absorbers. However, these solid odor absorbers, in addition to known activated charcoal odor absorbers, lose functionality when wet. Therefore, when wetted by body fluids or when carried in an aqueous solution, these odor absorbers are not preferred as they lose their desired odor absorbent characteristics. Furthermore, zeolites can cause "harsh” feel if too much is deposited onto the skin.
- an improved odor and moisture absorbing composition which is essentially free of irritating ingredients such as perfumes or astringent antiperspirants and which is safe and effective for use on the entire body. More particularly, there is a need for a convenient composition which is left on the skin and is capable of absorbing a broad spectrum of body odors and excess moisture that are not fully suppressed by the aforementioned means.
- a composition which is left on the skin, which incorporates odor absorbing, uncomplexed cyclodextrins; highly effective moisture absorbing ingredients; and a powder carrier.
- a particular advantage of the present invention is the ability to provide convenient, non-irritating odor and moisture protection when applied to occluded skin areas such as the pelvic region, the external vagina, the panty-area, the bra-line, and skin-folds, which may be very sensitive.
- the aforementioned benefits may be delivered in a powder carrier which also optionally delivers skin aid benefits to the user such as protection and/or moisturization.
- the present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1% to about 25%, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier.
- the present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5% to about 60%, by weight of the composition, of a highly effective moisture absorber.
- the compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants.
- the present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites.
- the present invention relates to a perfume-free, dry powder, odor absorbing, and optionally moisture absorbing composition.
- the present invention also relates to the use of the aforementioned powder composition in reducing body odor and excess moisture from occluded skin sites wherein the powdered composition is applied to occluded skin.
- the composition can be applied to occluded skin directly as a spray, shaken from a bottle or canister and applied by hand, or applied via wipe which is dry.
- composition of the present invention comprises dry ingredients preferably having particle sizes of from about 1 micron to about 100 microns; more preferred from about 1 micron to about 60 microns; and most preferred from about 1 micron to about 20 microns.
- particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles.
- occluded skin refers to regions of a human body covered by undergarments, such as the pelvic area, panty-area, and bra-line; and skin-folds or intertriginous regions, where there is continuing skin to skin contact.
- body fluids includes eccrine sweat, apocrine sweat, sebum, build up of sensible moisture from transepidermal water loss, vaginal discharge, urine, and mixtures thereof.
- excess moisture means an undesirable and/or unhealthy level of body fluids deposited on the human skin.
- body odor means odors which are generated as a result of the natural functioning of a human body. Such odors include, but are not limited to odors produced by microorganisms of the human skin (i.e. bacterial decomposition of skin secretions), urine, or vaginal discharge, and mixtures thereof.
- the term "entire body” means the entire external surface of human or mammalian skin.
- vaginal odor relates specifically to those body odors which emanate from the pelvic region of a woman, particularly the vagina and the panty area.
- cyclodextrin includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof.
- uncomplexed cyclodextrin as used herein means that the cavities within the cyclodextrin in the composition of the present invention should remain essentially unfilled prior to application to skin in order to allow the cyclodextrin to absorb various odor molecules when the composition is applied to the skin.
- cyclodextrins for use in the present invention are alpha-cyclodextrin, beta- cyclodextrin, gamma-cyclodextrin and/or their derivatives. More preferred are beta cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta-cyclodextrin, methylated-alpha-cyclodextrin or methylated-beta-cyclodextrin. Most preferred is beta- cyclodextrin.
- cyclodextrins absorb body odors more broadly by complexing with a wider range of odoriferous molecules having a wider range of molecular sizes.
- the levels of cyclodextrin are from about 0.1% to about 25%, preferably from about 1% to about 20%, more preferably from about 2% to about 15%, most preferably from about 3% to about 10%, by weight of the composition.
- Cyclodextrins having small particle sizes aid in providing higher cyclodextrin surface availability for odor absorption and therefore are preferred.
- the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles.
- Small particle cyclodexrins of this invention are those having a particle size of less than about 12 microns, preferably less than about 10 microns, and more preferably less than about 5 microns.
- a more complete description of the cyclodextrins, cyclodextrin derivatives, and cyclodextrin particle sizes useful in the present invention can be found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, which is incorporated herein by reference in its entirety.
- the cyclodextrins and other optional components useful in the present invention should be dispersed in a pharmaceutically-acceptable powder carrier for convenient, uniform application and disbursement onto the skin.
- pharmaceutically-acceptable means a powder suitable for topical use on the skin without undue toxicity, irritation, allergic response, and the like.
- the powder carrier also helps prevent any solubilized cyclodextrin from washing away from the desired skin contact.
- Powder carriers useful in the present invention include powders known in the art to be safe for human skin.
- Such powders include but are not limited to cornstarch (topical starch), talc, rice starch, oat starch, tapioca starch, microcrystalline cellulose (for example Avicel®), aluminum starch octenyl succinate (sold by National Starch & Chemical Co. as Dry Flo® Pure, Dry Flo® XT, and/or Dry Flo® PC), kaolin, and mixtures thereof.
- cornstarch topical starch
- talc rice starch
- oat starch tapioca starch
- microcrystalline cellulose for example Avicel®
- aluminum starch octenyl succinate sold by National Starch & Chemical Co. as Dry Flo® Pure, Dry Flo® XT, and/or Dry Flo® PC
- kaolin kaolin
- the powder carrier of the present invention will comprise from about 10% to about 95%, preferably from about 15% to about 80%, more preferably from about 25% to about 50%, by weight of the composition.
- HIGHLY EFFECTIVE MOISTURE ABSORBERS Highly effective moisture absorbers may optionally be included in the present invention to aid in reducing excess moisture on occluded skin. Highly effective moisture absorbers also increase the flowability (the ability to flow without caking due to moisture) of the compositions of the present invention.
- highly effective moisture absorbers refers to silicas (silicone dioxide), silicates or carbonates wherein the silicates and carbonates are formed by reaction of a carbonate or silicate with the alkali (IA) metals, alkaline earth (IIA) metals, or transition metals.
- Preferred highly effective moisture absorbers are calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, or zinc carbonate, and mixtures thereof.
- Synthetic versions of the highly effective moisture absorbers, particularly in regards to silicas and silicates due to safety risks related to crystalline silica. Synthetic versions are formed by controlled chemical reactions in a manufacturing process rather than using a natural, mined version of these compounds which is then further refined.
- Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker, Clark, and Daniels.
- Examples of synthetic calcium silicates useful in the present invention are Hubersorb® 250 or Hubersorb® 600 available from J.M. Huber.
- the highly effective moisture absorbers comprise from about 5% to about 60%; more preferred, from about 10% to about 50%; and most preferred, from about 20% to about 40% by weight of the total compo
- compositions of the present invention may comprise zeolites, carbon odor-controlling agents, sodium bicarbonates, antimicrobial agents and/or antiperspirant ingredients for added body odor control.
- zeolites refers to non-fibrous zeolites. When included in the present invention, zeolites may be present from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. A detailed description of zeolites useful in the present invention is found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, incorporated herein by reference in its entirety.
- Carbon odor-controlling agents described in U.S. Patent No. 5,429,628 may be used in the present invention at a level of from about 0.1% to about 25%, by weight of the composition.
- sodium bicarbonate is known in the art for its use as an odor absorber.
- An example of sodium bicarbonate and its use as an underarm deodorant is found in U.S. Patent No. 4,382,079, to Marschner, issued May 3, 1983, which is incorporated herein in its entirety by reference.
- sodium bicarbonate may be present from about 0.1% to about 50%, by weight of the composition.
- the antimicrobial agents of the present invention are selected from a group consisting of antibacterial agents, antifungal agents, and mixtures thereof. Antimicrobial agents help destroy and/or control the amount of bacteria and or fungi present on the skin.
- Preferred antimicrobial agents are zinc phenolsulfonate, zinc oxide, triclosan, Zelec® AM by DuPont, zinc ricinoleate, zinc undecylenate, and mixtures thereof. More preferred are zinc phenolsulfonate, zinc oxide, and triclosan. Triclosan is available from Ciba-Geigy as Irgasan DP-300. Examples of antimicrobial agents useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 10, which is incorporated herein by reference. When included in the present invention, the antimicrobials are at a level of from about 0.01% to about 25%. Preferably from about 0.1% to about 10%, by weight of the present composition.
- antiperspirant ingredients When used on the underarms, antiperspirant ingredients may be included in the present invention. Examples of antiperspirants known in the art are found in the Cosmetic Bench Reference. 1994 Edition, page 13, which is incorporated herein by reference. When included in the present invention, antiperspirants may be present from about 0.1% to about 25%, by weight of the composition.
- compositions of the present invention also optionally include skin aids.
- skin aids refers to skin protectants, emollients, and moisturizers.
- Skin protectants useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 53; and the Monograph on Skin Protectant Drug Products for Over-the-Counter Human Use, 21 CFR 347.
- Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oatmeal, and mixtures thereof.
- the skin protectants comprise from about 0.1% to about 80%, preferably from about 0.1% to about 30%, most preferably from about 0.1% to about 10%, by weight of the composition.
- Emollients and moisturizers useful in the present invention can be found in the Cosmetic Bench Reference. 1994 Edition, pages 27-32 and 46-48, incorporated herein by reference.
- Preferred emollients and moisturizers are tocopherol, tocopheryl acetate, aloe, vegetable oils, mineral oil, petrolatum, jojoba oil, and mixtures thereof. More preferred are encapsulated or spray/freeze dried emollients. The use of spray/freeze dried or encapsulated emollients keeps the emollients protected in the powder carrier until they are released through shearing (such as rubbing against undergarments or clothes) or through contact with skin moisture.
- emollients/moisturizers comprise from about 0.1% to about 50%, preferably from about
- compositions may optionally comprise slip compounds.
- slip compounds refers to compounds which have unique structures which provide enhanced slip/lubrication characteristics of powders and/or reduced skin to skin friction between intertriginous skin sites.
- Slip compounds of the present invention include polyethylene; nylon; polytetra- fluoroethylene; silica which is in the form of microspheres, ellipsoids, barrel-shapes, and the like; mica, silicone (e.g. dimethicone) and metallic stearates (e.g. zinc stearate); and mixtures thereof.
- Preferred slip compounds are silicas which are in the form of microspheres, ellipsoids, barrel-shapes, and the like.
- Silica ellipsoids useful in the present invention are available from DuPont as ZELEC® Sil.
- Silica microspheres are available from KOBO as MSS-500, MSS 500/3, MSS-500/H, MSS-500/3H, MSS-500/N, and MSS-500/3N. Additionally, it is preferred that some of the silica of the present invention be fumed silica for increased flowability of the powder in addition to enhancing the slip characteristics. Fumed silica is available from Cabot Corporation (Cab-O-Sil®) and from Degussa (Aerosil®).
- the slip compounds When present in the compositions of the invention, the slip compounds comprise from about 0.1% to about 35% , preferably from about 1% to about 10%, by weight of the composition.
- BINDERS The present invention may optionally also include dry or wet binders to help promote adhesion of the powder and active ingredients to the skin. Binders useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 13-14, which is incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropyl myristate, magnesium myristate, silicone, and mixtures thereof. More preferred are zinc stearate, dimethicone, and mixtures thereof.
- the binders When included in the composition, the binders are at a level of from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition.
- ANTI-PRUR ⁇ IC AGENTS Anti-pruritic agents such as those known in the art may be included in the compositions of the present invention. Examples of anti-pruritic agents useful in the present invention are Magnesium-L-Lactate, hydrocortisone, hydrocortisone acetate, and colloidal oatmeal. A description of anti-pruritic agents are found in the Handbook of Non Prescription Drugs. 10th Edition, p. 529, 1993; which is incorporated herein by reference. When included in the composition, anti-pruritic agents may be present from about 0.1% to about 40%, by weight of the composition..
- COLORANTS Colorants and dyes can be optionally added to the odor absorbing compositions for visual appeal and performance impression. Colorants suitable for use in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 21-22, which is incorporated herein by reference
- compositions of the present invention are prepared by the following steps: creating a mixture by mixing cyclodextrin, highly effective moisture absorbers (if present), and optional ingredients in a powder carrier via a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform; and creating a reduced size mixture using a commercially available size reduction technique such as hammer milling, impact milling, ball milling, or fluid energy milling until the desired particle size distribution is achieved.
- a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform
- a commercially available size reduction technique such as hammer milling, impact milling, ball milling, or fluid energy milling until the desired particle size distribution is achieved.
- compositions of the present invention are to be applied directly to the skin or hair, various applicators are useful for delivering the compositions to the occluded skin sites for maximum odor control.
- the compositions are preferably deposited in a bottle, a canister, a spray dispenser, a manually activated spray dispenser, or on a wipe structure which later is contacted with the skin to transfer the composition to the skin.
- Bottles and canisters known in the art are suitable for use in delivering the compositions of the present invention.
- Bottles and canisters preferably comprise lids with small apertures for convenient dispensing of the composition.
- composition of the present invention can also be delivered as a suspended solution via a spray dispenser or a bottle, such that when applied or sprayed onto the skin, the solvent would immediately dry/volatilize off to leave a powder film.
- suspension forms are aerosols, liquid powder suspensions, or silicone suspensions.
- the powders of the present invention When present in an aerosol composition, the powders of the present invention will usually be present in the range of from about 0.1% to about 15%, by weight of the composition.
- the incorporation of a powder into an aerosol is more fully explained in U.S. Patent No. 4,078,051, to Pomot et al., issued March 7, 1978; which is incorporated herein by reference in its entirety. This method is not preferred however for use on sensitive areas of the body such as the panty-area or other occluded skin areas since skin irritations may result from propellants commonly used in aerosol containers.
- a manually activated spray dispenser which delivers the composition as a powder without the use of propellants, and without the composition being in a solution form.
- Spray dispensers useful in the present invention are described more fully in U.S. Patent No. 2,450,205, to Rose, issued September 28, 1948; and U.S. Patent No. 2,840,277, to Bach, issued June 24, 1958, both of which are incorporated herein by reference in their entireties.
- the wipe comprises a flexible dispensing means.
- flexible dispensing means includes papers, cloths, non- wovens, films, foams, sponges, rollers, pads, tissues, cotton balls, and the like.
- Preferred wipe substrates comprise a porous material, such as the non-woven substrates, foams, or sponges, which are capable of holding the composition within the pores of the substrates. Examples of cellulosic non-wovens particularly useful and economic in the present invention is described in U.S. Patent Number 4,191,609, Trokhan, issued March 4, 1980 which is incorporated herein by reference in its entirety.
- compositions of the present invention are well known in the art. Examples of common methods of combining the composition to the wipe substrate may involve coating, immersing, dipping, sprinkling, or spraying, the wipe substrate with the composition of the present invention.
- the composition of the present invention is added to the wipe substrate at a level sufficient to provide the desired odor control and/or other desired skin benefits of the present invention.
- the present invention also encompasses the use of the compositions described herein in reducing body odor and excess moisture on a human comprising the application of the compositions described herein to occluded skin.
- the present invention also encompasses the use of the compositions described herein in reducing vaginal odor on a human comprising applying the compositions described herein onto a pelvic region, external vagina, and/or panty-area.
- the compositions of the present invention should not be inserted into the vagina, nor applied onto the vulva.
- an "effective amount" of the compositions of the present invention means an amount sufficient to absorb body odor and/or excess moisture to the point that body odor is not discernible by the human sense of smell and excess moisture is not present.
- compositions of the present invention are topically applied directly to the skin or hair.
- the compositions can be delivered by placing the composition into a dispensing means and applying an effective amount via spraying, sprinkling, shaking, or rubbing the composition onto the desired skin surface.
- the dispensing means is a canister, a spray bottle, or a pre-formed wipe which comprises a flexible dispensing means.
- the user may deposit the composition of the present invention onto a wipe comprising a flexible dispensing means of his or her own choosing.
- a flexible dispensing means such as a washcloth or puff
- the user may also use his her hand to apply the compositions of the present invention.
- the user may use as much or as little of the composition of the present invention as he/she desires, depending upon their intended use and degree of odor and moisture control necessary.
- the following non-limiting examples illustrate the formulations and methods of use of the present invention.
- Examples I and II may also comprise a colorant and/or an anti-pruitic agent such as Magnesium-L-Lactate.
- Zinc Stearate 5.00 Zinc Stearate 5.00
- Tocopheryl Acetate Oil (Vit. E. 3.00 Mineral Oil 5.00
- Example III may also comprise a zeolite.
- EXAMPLE V EXAMPLE VI
- Examples V and VI may also comprise sodium bicarbonate.
- Example VII and VIII may also comprise an anti-pruritic agent such as Magnesium-L- Lactate.
- an anti-pruritic agent such as Magnesium-L- Lactate.
- Examples LX and X may also comprise a zeolite and/or a colorant.
- EXAMPLE XI EXAMPLE XII
- Corn Starch (Topical Starch) 10.25 Corn Starch (Topical Starch) 8.80 Oat Flour/Colloidal Oatmeal 8.35 Kaolin 4.00
- Examples XIII and XTV may also comprise sodium bicarbonate.
- compositions of the present invention such as those formed from the examples may be loaded onto a wipe or deposited into a spray device or canister.
- the compositions may be applied directly onto the skin or into/onto a flexible dispensing means of the user's choosing for convenient application to the skin.
- Example XV A woman with stress urinary incontinence finds that the wetness associated with this condition causes vaginal odor and discomfort. She wishes to reduce both the excess moisture and the vaginal odor. After urinating, the woman wipes her external vagina and pelvic region with a wipe containing the composition in Example VI. The woman notices less odor after using the wipes. Alternatively, the woman uses the composition in Example XIV and notices less odor and less moisture after using the wipes.
- Example XVI A large-breasted woman finds that when she exercises, she tends to experience sweating and skin chafing under the breasts. Before and after exercising, she applies the composition from Example III via a manual spray bottle. She sprays the composition under her breasts and the woman notices less odor and feels more comfortable after using the powder spray. Alternatively, the woman uses the composition in Example XrV and notices less odor and less moisture after using the wipes.
- Example XVII A man has severe allergies to cosmetic deodorants and antiperspirants and avoids using such products. This results in uncontrolled and embarrassing body odor due to excess moisture build up. His doctor suggests applying the mild odor and moisture absorbing composition of Example I or VIII. The man applies the composition to his entire body via a spray each morning after showering, and suffers no allergic reaction. The man notices less odor when using the composition of either Example I or VIII, and notices a marked reduction of moisture with the composition of Example VIII. The man keeps a pouch of wipes at work, which also contain the composition of Example VIII, for convenient and discrete reapplication as needed, particularly on hot and sweaty days.
- Example XVHI An obese woman has several large abdominal skin folds wherein excess moisture often accumulates causing body odor. She wishes to reduce her body odor as well as the excess moisture. The woman applies the composition of Example IV by sprinkling the composition from a bottle into the palm of her hand and rubbing the composition into the intertriginous regions between her skin folds as well as other occluded skin sites. The woman notices less odor. Alternatively, the woman uses the composition in Example XI and notices less odor and less moisture after using the wipes.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
The present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1 % to about 25 %, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier. The present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5 % to about 60 %, by weight of the composition, of a highly effective moisture absorber. The compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants. The present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites.
Description
COMPOSITIONS FOR REDUCING BODY ODORS AND EXCESS MOISTURE
BACKGROUND OF THE INVENTION
Body odor is most commonly caused by fatty acids on skin and by malodors from microbial sources. The human skin is naturally populated with numerous micro-organisms which are nourished by various skin secreted substances (eccrine and apocrine sweat, and sebum), skin cell debris, breakdown products of the skin and the organisms themselves. These unpleasant body odors are mainly organic molecules which have different structures and functional groups, such as amines, acids, alcohols, aldehydes, ketones, phenolics, polycyclics, indoles, aromatics, polyaromatics, etc. They can also be made up of sulfur- containing functional groups, such as, thiol, mercaptan, sulf.de and/or disulfide groups.
Numerous attempts have been made to control or absorb body odors. Attempts have been made to deprive the microbials responsible for body odor of the moist/humid environment they need to proliferate and grow. Such efforts include the use of powders and/or antiperspirants. Body powders and powder-based compositions of the prior art have limited absorption capabilities. Antiperspirants are not always preferred in a body odor control product since, when used over the entire body, they may interfere with the body's thermal regulatory process by inhibiting perspiration through the action of astringent salts. Additionally, such salts may be irritating to a large number of users, particularly when applying them to sensitive areas such as the pelvic region.
Other deodorant compositions aimed at combating controlling odor associated with skin secretions, which have been described in the chemical and cosmetic literature, include emulsion sticks or suspensoid sticks, aerosols, roll-ons, pads, pump sprays, and even soap bars. These known deodorants attempt to control odor through a variety of means. For instance, U.S. Patent No. 5,525,331, to Betts, issued June 11, 1996, discloses compositions which inhibit the growth of micro-organisms in the body-secretions. Deodorants may also include antibacterial compounds which help destroy/control the amount of bacteria present on skin, thereby minimising odor produced via bacterial metabolism of skin secretions.
Zeolites are known odor absorbers. However, these solid odor absorbers, in addition to known activated charcoal odor absorbers, lose functionality when wet. Therefore, when wetted by body fluids or when carried in an aqueous solution, these odor absorbers are not preferred as they lose their desired odor absorbent characteristics. Furthermore, zeolites can cause "harsh" feel if too much is deposited onto the skin.
In addition to the aforementioned attempts at controlling and/or absorbing body odor, numerous attempts have been made to mask body odors with other odors or perfumes. However, perfumes are often inadequate at fully concealing body odors and may be irritating
to the user when used alone for control odor.
Thus, there remains a need for an improved odor and moisture absorbing composition, which is essentially free of irritating ingredients such as perfumes or astringent antiperspirants and which is safe and effective for use on the entire body. More particularly, there is a need for a convenient composition which is left on the skin and is capable of absorbing a broad spectrum of body odors and excess moisture that are not fully suppressed by the aforementioned means.
It has been discovered that such enhanced body odor and moisture control can be safely provided to the entire body by applying a composition, which is left on the skin, which incorporates odor absorbing, uncomplexed cyclodextrins; highly effective moisture absorbing ingredients; and a powder carrier. It has been discovered that a particular advantage of the present invention is the ability to provide convenient, non-irritating odor and moisture protection when applied to occluded skin areas such as the pelvic region, the external vagina, the panty-area, the bra-line, and skin-folds, which may be very sensitive. Moreover, it has been discovered that the aforementioned benefits may be delivered in a powder carrier which also optionally delivers skin aid benefits to the user such as protection and/or moisturization.
These and other objects of the present invention will become readily apparent from the detailed description which follows.
All percentages, ratios, and parts herein, in the Specification, Examples, and Claims are by weight unless otherwise stated. The term "g", as used herein, means gram. The term "ml", as used herein, means milliliter.
SUMMARY OF THE INVENTION
The present invention relates to a perfume-free powder, odor absorbing composition, which is safe for use on skin comprising from about 0.1% to about 25%, by weight of the composition, of uncomplexed cyclodextrin; and a powder carrier. The present invention also relates to a powder odor and moisture absorbing composition which additionally comprises from about 5% to about 60%, by weight of the composition, of a highly effective moisture absorber. The compositions of the present invention may also contain additional odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants.
The present invention also relates to the use of the aforementioned compositions in reducing body odor and excess moisture on occluded skin sites.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a perfume-free, dry powder, odor absorbing, and optionally moisture absorbing composition. The present invention also relates to the use of the aforementioned powder composition in reducing body odor and excess moisture from occluded skin sites wherein the powdered composition is applied to occluded skin. The
composition can be applied to occluded skin directly as a spray, shaken from a bottle or canister and applied by hand, or applied via wipe which is dry.
The composition of the present invention comprises dry ingredients preferably having particle sizes of from about 1 micron to about 100 microns; more preferred from about 1 micron to about 60 microns; and most preferred from about 1 micron to about 20 microns. As used herein, the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles.
The term "occluded skin", as used herein, refers to regions of a human body covered by undergarments, such as the pelvic area, panty-area, and bra-line; and skin-folds or intertriginous regions, where there is continuing skin to skin contact.
The term "body fluids", as used herein, includes eccrine sweat, apocrine sweat, sebum, build up of sensible moisture from transepidermal water loss, vaginal discharge, urine, and mixtures thereof.
The term "excess moisture", as used herein, means an undesirable and/or unhealthy level of body fluids deposited on the human skin.
The term "body odor" as used herein means odors which are generated as a result of the natural functioning of a human body. Such odors include, but are not limited to odors produced by microorganisms of the human skin (i.e. bacterial decomposition of skin secretions), urine, or vaginal discharge, and mixtures thereof.
The term "entire body" means the entire external surface of human or mammalian skin.
The term "vaginal odor" relates specifically to those body odors which emanate from the pelvic region of a woman, particularly the vagina and the panty area.
A detailed description of essential and optional components of the present invention is given below.
CYCLODEXTRIN As used herein, the term "cyclodextrin" includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof.
The term "uncomplexed cyclodextrin" as used herein means that the cavities within the cyclodextrin in the composition of the present invention should remain essentially unfilled prior to application to skin in order to allow the cyclodextrin to absorb various odor molecules when the composition is applied to the skin.
Preferred cyclodextrins for use in the present invention are alpha-cyclodextrin, beta- cyclodextrin, gamma-cyclodextrin and/or their derivatives. More preferred are beta cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta-cyclodextrin, methylated-alpha-cyclodextrin or methylated-beta-cyclodextrin. Most preferred is beta-
cyclodextrin.
It is also preferable to use a mixture of cyclodextrins. Such mixtures absorb body odors more broadly by complexing with a wider range of odoriferous molecules having a wider range of molecular sizes. The levels of cyclodextrin are from about 0.1% to about 25%, preferably from about 1% to about 20%, more preferably from about 2% to about 15%, most preferably from about 3% to about 10%, by weight of the composition.
The complexation between cyclodextrin and odorous molecules occurs rapidly when wetted with body fluids. This is convenient for the user because the cyclodextrins, while on dry skin, will not fill their cavities with other environmental odors which would otherwise render them less efficient for absorbing body odors. More particularly, upon solubilization of the cyclodextrins by the body fluids, the isolated cavities become available to form inclusion complexes with the body odor molecules. Thus, ultimately, the availability of solubilized uncomplexed cyclodextrin is essential for an effective and efficient odor control performance.
Cyclodextrins having small particle sizes aid in providing higher cyclodextrin surface availability for odor absorption and therefore are preferred. As used herein, the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles. Small particle cyclodexrins of this invention are those having a particle size of less than about 12 microns, preferably less than about 10 microns, and more preferably less than about 5 microns. A more complete description of the cyclodextrins, cyclodextrin derivatives, and cyclodextrin particle sizes useful in the present invention can be found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, which is incorporated herein by reference in its entirety.
POWDER CARRIER The cyclodextrins and other optional components useful in the present invention should be dispersed in a pharmaceutically-acceptable powder carrier for convenient, uniform application and disbursement onto the skin. The term "pharmaceutically-acceptable", as used herein, means a powder suitable for topical use on the skin without undue toxicity, irritation, allergic response, and the like. The powder carrier also helps prevent any solubilized cyclodextrin from washing away from the desired skin contact. Powder carriers useful in the present invention include powders known in the art to be safe for human skin. Such powders include but are not limited to cornstarch (topical starch), talc, rice starch, oat starch, tapioca starch, microcrystalline cellulose (for example Avicel®), aluminum starch octenyl succinate (sold by National Starch & Chemical Co. as Dry Flo® Pure, Dry Flo® XT, and/or Dry Flo® PC), kaolin, and mixtures thereof. Preferred is cornstarch.
The powder carrier of the present invention will comprise from about 10% to about 95%, preferably from about 15% to about 80%, more preferably from about 25% to about 50%, by weight of the composition.
HIGHLY EFFECTIVE MOISTURE ABSORBERS Highly effective moisture absorbers may optionally be included in the present invention to aid in reducing excess moisture on occluded skin. Highly effective moisture absorbers also increase the flowability (the ability to flow without caking due to moisture) of the compositions of the present invention. As used herein, the phrase "highly effective moisture absorbers" refers to silicas (silicone dioxide), silicates or carbonates wherein the silicates and carbonates are formed by reaction of a carbonate or silicate with the alkali (IA) metals, alkaline earth (IIA) metals, or transition metals. Preferred highly effective moisture absorbers are calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, or zinc carbonate, and mixtures thereof. Some specific examples of the silicates and carbonates useful in the present invention are more fully explained in Van Nostrand Reinhold's Encyclopedia of Chemistry. 4th Ed. pages 155, 169, 556, and 849, (1984), which is incorporated herein by reference.
Preferred are synthetic versions of the highly effective moisture absorbers, particularly in regards to silicas and silicates due to safety risks related to crystalline silica. Synthetic versions are formed by controlled chemical reactions in a manufacturing process rather than using a natural, mined version of these compounds which is then further refined.
Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker, Clark, and Daniels. Examples of synthetic calcium silicates useful in the present invention are Hubersorb® 250 or Hubersorb® 600 available from J.M. Huber.
It is preferred that the highly effective moisture absorbers comprise from about 5% to about 60%; more preferred, from about 10% to about 50%; and most preferred, from about 20% to about 40% by weight of the total compo
ADJUNCT ODOR CONTROLLING AGENTS Optionally, the compositions of the present invention may comprise zeolites, carbon odor-controlling agents, sodium bicarbonates, antimicrobial agents and/or antiperspirant ingredients for added body odor control.
The term "zeolite", as used herein, refers to non-fibrous zeolites. When included in the present invention, zeolites may be present from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. A detailed description of zeolites useful in the present invention is found in U.S. Patent No. 5,429,628, Trinh et al., issued July 4, 1995, incorporated herein by reference in its entirety.
Carbon odor-controlling agents described in U.S. Patent No. 5,429,628 may be used in the present invention at a level of from about 0.1% to about 25%, by weight of the composition.
Sodium bicarbonate is known in the art for its use as an odor absorber. An example of sodium bicarbonate and its use as an underarm deodorant is found in U.S. Patent No. 4,382,079, to Marschner, issued May 3, 1983, which is incorporated herein in its entirety by
reference. When included in the present invention, sodium bicarbonate may be present from about 0.1% to about 50%, by weight of the composition.
The antimicrobial agents of the present invention are selected from a group consisting of antibacterial agents, antifungal agents, and mixtures thereof. Antimicrobial agents help destroy and/or control the amount of bacteria and or fungi present on the skin. Preferred antimicrobial agents are zinc phenolsulfonate, zinc oxide, triclosan, Zelec® AM by DuPont, zinc ricinoleate, zinc undecylenate, and mixtures thereof. More preferred are zinc phenolsulfonate, zinc oxide, and triclosan. Triclosan is available from Ciba-Geigy as Irgasan DP-300. Examples of antimicrobial agents useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 10, which is incorporated herein by reference. When included in the present invention, the antimicrobials are at a level of from about 0.01% to about 25%. Preferably from about 0.1% to about 10%, by weight of the present composition.
When used on the underarms, antiperspirant ingredients may be included in the present invention. Examples of antiperspirants known in the art are found in the Cosmetic Bench Reference. 1994 Edition, page 13, which is incorporated herein by reference. When included in the present invention, antiperspirants may be present from about 0.1% to about 25%, by weight of the composition.
SKIN AIDS The compositions of the present invention also optionally include skin aids. The term "skin aids", as used herein, refers to skin protectants, emollients, and moisturizers.
Skin protectants useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, page 53; and the Monograph on Skin Protectant Drug Products for Over-the-Counter Human Use, 21 CFR 347. Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oatmeal, and mixtures thereof. When present, the skin protectants comprise from about 0.1% to about 80%, preferably from about 0.1% to about 30%, most preferably from about 0.1% to about 10%, by weight of the composition.
Emollients and moisturizers useful in the present invention can be found in the Cosmetic Bench Reference. 1994 Edition, pages 27-32 and 46-48, incorporated herein by reference. Preferred emollients and moisturizers are tocopherol, tocopheryl acetate, aloe, vegetable oils, mineral oil, petrolatum, jojoba oil, and mixtures thereof. More preferred are encapsulated or spray/freeze dried emollients. The use of spray/freeze dried or encapsulated emollients keeps the emollients protected in the powder carrier until they are released through shearing (such as rubbing against undergarments or clothes) or through contact with skin moisture. Examples of preferred commercial spray/freeze dried aloe useful in the present invention are Terra-Dry™ Freeze Dried Aloe, Terra-Pure™ Freeze or Spray Dried Aloe, and Terra-Spray ™ Spray Dried Aloe, all from Terry Laboratories. When present, the
emollients/moisturizers comprise from about 0.1% to about 50%, preferably from about
0.1% to about 25%, most preferably from about 0.1% to about 10%, by weight of the composition.
SLIP COMPOUNDS The present compositions may optionally comprise slip compounds.
The term "slip compounds", as used herein, refers to compounds which have unique structures which provide enhanced slip/lubrication characteristics of powders and/or reduced skin to skin friction between intertriginous skin sites.
Slip compounds of the present invention include polyethylene; nylon; polytetra- fluoroethylene; silica which is in the form of microspheres, ellipsoids, barrel-shapes, and the like; mica, silicone (e.g. dimethicone) and metallic stearates (e.g. zinc stearate); and mixtures thereof. Preferred slip compounds are silicas which are in the form of microspheres, ellipsoids, barrel-shapes, and the like. Silica ellipsoids useful in the present invention are available from DuPont as ZELEC® Sil. Silica microspheres are available from KOBO as MSS-500, MSS 500/3, MSS-500/H, MSS-500/3H, MSS-500/N, and MSS-500/3N. Additionally, it is preferred that some of the silica of the present invention be fumed silica for increased flowability of the powder in addition to enhancing the slip characteristics. Fumed silica is available from Cabot Corporation (Cab-O-Sil®) and from Degussa (Aerosil®).
When present in the compositions of the invention, the slip compounds comprise from about 0.1% to about 35% , preferably from about 1% to about 10%, by weight of the composition.
BINDERS The present invention may optionally also include dry or wet binders to help promote adhesion of the powder and active ingredients to the skin. Binders useful in the present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 13-14, which is incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropyl myristate, magnesium myristate, silicone, and mixtures thereof. More preferred are zinc stearate, dimethicone, and mixtures thereof.
When included in the composition, the binders are at a level of from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. ANTI-PRURΓΓIC AGENTS Anti-pruritic agents such as those known in the art may be included in the compositions of the present invention. Examples of anti-pruritic agents useful in the present invention are Magnesium-L-Lactate, hydrocortisone, hydrocortisone acetate, and colloidal oatmeal. A description of anti-pruritic agents are found in the Handbook of Non Prescription Drugs. 10th Edition, p. 529, 1993; which is incorporated herein by reference. When included in the composition, anti-pruritic agents may be present from about 0.1% to about 40%, by weight of the composition..
COLORANTS Colorants and dyes can be optionally added to the odor absorbing compositions for visual appeal and performance impression. Colorants suitable for use in the
present invention are found in the Cosmetic Bench Reference. 1994 Edition, pages 21-22, which is incorporated herein by reference
PROCESS OF MAKING COMPOSITIONS
The compositions of the present invention are prepared by the following steps: creating a mixture by mixing cyclodextrin, highly effective moisture absorbers (if present), and optional ingredients in a powder carrier via a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform; and creating a reduced size mixture using a commercially available size reduction technique such as hammer milling, impact milling, ball milling, or fluid energy milling until the desired particle size distribution is achieved.
Since the compositions of the present invention are to be applied directly to the skin or hair, various applicators are useful for delivering the compositions to the occluded skin sites for maximum odor control. For example, the compositions are preferably deposited in a bottle, a canister, a spray dispenser, a manually activated spray dispenser, or on a wipe structure which later is contacted with the skin to transfer the composition to the skin.
Bottles and canisters known in the art are suitable for use in delivering the compositions of the present invention. Bottles and canisters preferably comprise lids with small apertures for convenient dispensing of the composition.
The composition of the present invention can also be delivered as a suspended solution via a spray dispenser or a bottle, such that when applied or sprayed onto the skin, the solvent would immediately dry/volatilize off to leave a powder film. Examples of such suspension forms are aerosols, liquid powder suspensions, or silicone suspensions. When present in an aerosol composition, the powders of the present invention will usually be present in the range of from about 0.1% to about 15%, by weight of the composition. The incorporation of a powder into an aerosol is more fully explained in U.S. Patent No. 4,078,051, to Pomot et al., issued March 7, 1978; which is incorporated herein by reference in its entirety. This method is not preferred however for use on sensitive areas of the body such as the panty-area or other occluded skin areas since skin irritations may result from propellants commonly used in aerosol containers.
Preferred is a manually activated spray dispenser which delivers the composition as a powder without the use of propellants, and without the composition being in a solution form. Spray dispensers useful in the present invention are described more fully in U.S. Patent No. 2,450,205, to Rose, issued September 28, 1948; and U.S. Patent No. 2,840,277, to Bach, issued June 24, 1958, both of which are incorporated herein by reference in their entireties.
Any wipe structures and/or methods of making the wipe structures commonly known in the art may be used in the present invention. The wipe comprises a flexible dispensing means. The term "flexible dispensing means", as used herein, includes papers, cloths, non-
wovens, films, foams, sponges, rollers, pads, tissues, cotton balls, and the like. Preferred wipe substrates comprise a porous material, such as the non-woven substrates, foams, or sponges, which are capable of holding the composition within the pores of the substrates. Examples of cellulosic non-wovens particularly useful and economic in the present invention is described in U.S. Patent Number 4,191,609, Trokhan, issued March 4, 1980 which is incorporated herein by reference in its entirety.
Techniques for combining the wipe substrates with the composition of the present invention are well known in the art. Examples of common methods of combining the composition to the wipe substrate may involve coating, immersing, dipping, sprinkling, or spraying, the wipe substrate with the composition of the present invention. The composition of the present invention is added to the wipe substrate at a level sufficient to provide the desired odor control and/or other desired skin benefits of the present invention.
USE OF THE POWDER COMPOSITION
The present invention also encompasses the use of the compositions described herein in reducing body odor and excess moisture on a human comprising the application of the compositions described herein to occluded skin. The present invention also encompasses the use of the compositions described herein in reducing vaginal odor on a human comprising applying the compositions described herein onto a pelvic region, external vagina, and/or panty-area. However, the compositions of the present invention should not be inserted into the vagina, nor applied onto the vulva.
An "effective amount" of the compositions of the present invention, as used herein, means an amount sufficient to absorb body odor and/or excess moisture to the point that body odor is not discernible by the human sense of smell and excess moisture is not present.
The compositions of the present invention are topically applied directly to the skin or hair. The compositions can be delivered by placing the composition into a dispensing means and applying an effective amount via spraying, sprinkling, shaking, or rubbing the composition onto the desired skin surface. Preferably the dispensing means is a canister, a spray bottle, or a pre-formed wipe which comprises a flexible dispensing means.
Alternatively, the user may deposit the composition of the present invention onto a wipe comprising a flexible dispensing means of his or her own choosing. To do this, the user simply chooses a flexible dispensing means such as a washcloth or puff; transfers the composition of the present invention from a bottle or other suitable container over the chosen flexible dispensing means, and applies the composition to the desired area of the body. The user may also use his her hand to apply the compositions of the present invention. The user may use as much or as little of the composition of the present invention as he/she desires, depending upon their intended use and degree of odor and moisture control necessary.
The following non-limiting examples illustrate the formulations and methods of use of the present invention.
EXAMPLE I EXAMPLE II
Ingredient %W/W Ingredient %W/W
Corn Starch (Topical Starch) 64.80 Corn Starch (Topical Starch) 52.20
Silica (Microspheres) 2.00 Talc 10.00
Fumed Silica 2.00 Silica (Microspheres) 3.00
Zinc Phenolsulfonate 3.00 Fumed Silica 1.00
Triclosan .20 Zinc Phenolsulfonate 3.00
Cyclodextrin 3.00 Triclosan 0.30
Aloe Vera, Freeze/Spray Dried 1.00 Cyclodextrin 13.00
Nylon- 12 5.00 Aloe Vera, Freeze/Spray Dried 0.50
Zinc Stearate 7.00 Nylon- 12 5.00
Tocopheryl Acetate 2.00 Zinc Stearate 3.00
Microcapsules
Dimethicone 10.00 Tocopheryl Acetate 2.00 Microcapsules
Mineral Oil 2.00
Dimethicone 5.00
Total 100.00 Total 100.00
Examples I and II may also comprise a colorant and/or an anti-pruitic agent such as Magnesium-L-Lactate.
EXAMPLE III EXAMPLE IV
Ingredient %w/w Ingredient %W/W
Rice Starch 54.50 Aluminum Starch Octenyl 30.80 Succinate (Dry Flo®Pure)
Mica 2.00 Silica (Ellipsoids) 4.00
Silica (Ellipsoids) 2.00 Zinc Phenolsulfonate 7.00
Fumed Silica 1.00 Triclosan 0.60
Triclosan 0.50 Cyclodextrin 10.00
Aluminum Chlorohydrate 5.00 Aloe Vera Gel/Oil 1.00
Cyclodextrin 6.00 Zeolite 10.00
Aloe Vera, Freeze/Spray Dried 1.00 Talc 13.60
Polyethylene Powder 5.00 Polyethylene Powder 7.00
Zinc Stearate 5.00 Zinc Stearate 5.00
Tocopheryl Acetate Oil (Vit. E. 3.00 Mineral Oil 5.00
Acetate)
Dimethicone 10.00 Dimethicone 6.00
Nylon N- 12 5.00
Total 100.00 Total 100.00
Example III may also comprise a zeolite.
EXAMPLE V EXAMPLE VI
Ingredient %W W Ingredient %W W
Tapioca Starch 54.60 Corn Starch (Topical Starch) 29.25
Talc 4.90 Oat Flour/Colloidal Oatmeal 16.35
Silica (Microspheres) 2.50 Silica (Microspheres) 2.50
Fumed Silica 2.00 Silica (Ellipsoids) 1.50
Zinc Oxide 4.00 Kaolin 8.00
Triclosan 1.00 Zinc Oxide 2.00
Cyclodextrin 4.00 Triclosan 0.40
Aloe Vera Gel/Oil 2.00 Cyclodextrin 5.00
Nylon-12 10.00 Aloe Vera Gel/Oil 2.00
Zinc Stearate 6.00 Nylon-12 4.00
Isopropyl Myristate 4.00 Polyethylene Powder 4.00
Dimethicone 5.00 Zinc Stearate 10.00
Tocopheryl Acetate 5.00
Mircocapsules
Dimethicone 10.00
Total 100.00 Total 100.00
Examples V and VI may also comprise sodium bicarbonate.
EXAMPLE VII EXAMPLE Vm
Ingredient %W W Ingredient %WAV
Corn Starch (Topical Starch) 50.80 Corn Starch (Topical Starch) 26.70
Kaolin 14.50 Silica (Microspheres) 10.00
Silica (Microspheres) 2.50 Fumed Silica 5.00
Silica (Ellipsoids) 1.50 Zinc Phenolsulfonate 3.00
Fumed Silica 0.50 Triclosan 0.20
Zinc Phenolsulfonate 2.00 Cyclodextrin 3.00
Triclosan 0.20 Aloe Vera, Freeze/Spray Dried 0.10
Cyclodextrin 8.00 Magnesium Carbonate 8.00
Aloe Vera Gel/Oil 3.00 Nylon-12 5.00
Nylon-12 2.00 Calcium Silicate 20.00
Polyethylene Powder 5.00 Zinc Stearate 7.00
Tocopheryl Acetate 3.00 Tocopheryl Acetate 2.00
Microcapsules Mircocapsules
Isopropyl Myristate 2.00 Dimethicone 10.00
Dimethicone 5.00
Total 100.00 Total 100.00
Example VII and VIII may also comprise an anti-pruritic agent such as Magnesium-L- Lactate.
EXAMPLE IX EXAMPLE X
Ingredient %W/W Ingredient %W/W
Corn Starch (Topical Starch) 23.20 Rice Starch 23.40
Talc 10.00 Mica 2.00
Silica (Microspheres) 10.00 Silica (Ellipsoids) 14.50
Fumed Silica 5.00 Fumed Silica 5.00
Zinc Phenolsulfonate 3.00 Triclosan 0.10
Triclosan 0.30 Aluminum Chlorohydrate 5.00
Cyclodextrin 3.00 Cyclodextrin 6.00
Aloe Vera, Freeze/Spray Dried 0.50 Aloe Vera, Freeze/Spray Dried 1.00
Magnesium Carbonate 8.00 Calcium Carbonate 10.00
Nylon-12 5.00 Polyethylene Powder 3.00
Calcium Silicate 20.00 Calcium Silicate 10.00
Zinc Stearate 3.00 Zinc Stearate 7.00
Tocopheryl Acetate 2.00 Tocopheryl Acetate Oil (Vit. E 3.00
Microcapsules Acetate)
Mineral Oil 2.00 Dimethicone 10.00
Dimethicone 5.00
Total 100.00 Total 100.00
Examples LX and X may also comprise a zeolite and/or a colorant. EXAMPLE XI EXAMPLE XII
Ingredient %W/W Ingredient %W/W
Aluminum Starch Octenyl 17.40 Tapioca Starch 13.10
Succinate
Silica (Ellipsoids) 8.00 Talc 4.90
Fumed Silica 8.00 Silica (Microspheres) 20.00
Zinc Phenolsulfonate 7.00 Fumed Silica 2.00
Triclosan 0.60 Zinc Oxide 4.00
Cyclodextrin 10.00 Triclosan 1.00
Aloe Vera Gel/Oil 1.00 Cyclodextrin 4.00
Magnesium Carbonate 7.00 Aloe Vera Gel/Oil 2.00
Calcium Carbonate 3.00 Magnesium Carbonate 5.00
Polyethylene Powder 7.00 Calcium Carbonate 4.00
Calcium Silicate 15.00 Nylon-12 10.00
Zinc Stearate 5.00 Calcium Silicate 15.00
Mineral Oil 5.00 Zinc Stearate 6.00
Dimethicone 6.00 Isopropyl Myristate 4.00
Dimethicone 5.00
Total 100.00 Total 100.00
EXAMPLE XIII EXAMPLE XIV
Ingredient %W/W Ingredient %w/w
Corn Starch (Topical Starch) 10.25 Corn Starch (Topical Starch) 8.80
Oat Flour/Colloidal Oatmeal 8.35 Kaolin 4.00
Silica (Microspheres) 5.00 Silica (Microspheres) 5.00
Silica (Ellipsoids) 10.00 Silica (Ellipsoids) 5.00
Fumed Silica 5.00 Fumed Silica 5.00
Zinc Oxide 2.00 Zinc Phenolsulfonate 2.00
Triclosan 0.40 Triclosan 0.20
Cyclodextrin 5.00 Cyclodextrin 8.00
Aloe Vera Gel/Oil 2.00 Aloe Vera Gel/Oil 3.00
Magnesium Carbonate 4.00 Magnesium Carbonate 10.00
Calcium Carbonate 5.00 Nylon-12 2.00
Nylon-12 4.00 Polyethylene Powder 5.00
Polyethylene Powder 4.00 Calcium Silicate 25.00
Calcium Silicate 10.00 Zinc Stearate 7.00
Zinc Stearate 10.00 Tocopheryl Acetate 3.00 Microcapsules
Tocopheryl Acetate 5.00 Isopropyl Myristate 2.00
Microcapsules
Dimethicone 10.00 Dimethicone 5.00
Total 100.00 Total 100.00
Examples XIII and XTV may also comprise sodium bicarbonate.
Prepare the above Examples by the following steps: create a mixture by mixing cyclodextrin, highly effective moisture absorbers, optional dry ingredients, and a powder carrier in a commercially available mixer such as a vee-blender, double cone blender, or ribbon blender until the mixture is uniform; reduce the particle size of the mixture using a grinding/pulverizing technique such as hammer milling, impact milling, ball milling, or fluid energy milling; and create a second mixture by adding any liquid phase emollients, moisturizers, and or skin protectants to the mixture, preferably using spray atomization while mixing for a more even dispersion. The second mixture can then undergo a second pulverizing grinding step, and if desired, an air classifying operation. Preparation for Application to Skin:
The compositions of the present invention, such as those formed from the examples may be loaded onto a wipe or deposited into a spray device or canister. The compositions may be applied directly onto the skin or into/onto a flexible dispensing means of the user's choosing for convenient application to the skin.
To prepare wipes: Coat, sprinkle, or spray the composition onto a dry flexible dispensing means until desired coating or thickness of the composition on the flexible dispensing means is achieved.
To prepare sprav: Deposit the composition into the selected spray package. Close the package for storage until consumer use. To prepare a pressurized aerosol spray, transfer the composition into a suitable container. Pressurize and seal the container after injection of propellant materials.
Example XV A woman with stress urinary incontinence finds that the wetness associated with this condition causes vaginal odor and discomfort. She wishes to reduce both the excess moisture and the vaginal odor. After urinating, the woman wipes her external vagina and pelvic region with a wipe containing the composition in Example VI. The woman notices less odor after using the wipes. Alternatively, the woman uses the composition in Example XIV and notices less odor and less moisture after using the wipes.
Example XVI A large-breasted woman finds that when she exercises, she tends to experience sweating and skin chafing under the breasts. Before and after exercising, she applies the composition from Example III via a manual spray bottle. She sprays the composition under her breasts and the woman notices less odor and feels more comfortable after using the powder spray. Alternatively, the woman uses the composition in Example XrV and notices less odor and less moisture after using the wipes.
Example XVII A man has severe allergies to cosmetic deodorants and antiperspirants and avoids using such products. This results in uncontrolled and embarrassing body odor due to excess moisture build up. His doctor suggests applying the mild odor and moisture absorbing composition of Example I or VIII. The man applies the composition to his entire body via a spray each morning after showering, and suffers no allergic reaction. The man notices less odor when using the composition of either Example I or VIII, and notices a marked reduction of moisture with the composition of Example VIII. The man keeps a pouch of wipes at work, which also contain the composition of Example VIII, for convenient and discrete reapplication as needed, particularly on hot and sweaty days.
Example XVHI An obese woman has several large abdominal skin folds wherein excess moisture often accumulates causing body odor. She wishes to reduce her body odor as well as the excess moisture. The woman applies the composition of Example IV by sprinkling the composition from a bottle into the palm of her hand and rubbing the composition into the intertriginous regions between her skin folds as well as other occluded skin sites. The woman notices less odor. Alternatively, the woman uses the composition in Example XI and notices less odor and less moisture after using the wipes.
Claims
1. An odor absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; and b. a powder carrier; and wherein said composition is safe for use on skin.
2. The composition according to Claim 1 further comprising slip compounds.
3. An odor and moisture absorbing composition comprising: a. 0.1 % to 25 %, by weight of the composition, of uncomplexed cyclodextrin; b. a powder carrier; and c. 5% to 60%, by weight of the composition, of a highly effective moisture absorber; and wherein said composition is safe for use on skin.
4. The composition of Claim 3 wherein the highly effective moisture absorbers are selected from the group consisting of silicates, silicas, and carbonates.
5. The composition of Claim 4 wherein the highly effective moisture absorbers are selected from the group consisting of calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, and zinc carbonate.
6. The composition according to any one of the preceding Claims wherein the cyclodextrin is selected from the group consisting of beta-cyclodextrins, derivatives of beta- cyclodextrins, alpha-cyclodextrins, derivatives of alpha-cyclodextrins, gamma-cyclodextrins, derivatives of gamma-cyclodextrins, and mixtures thereof.
7. The composition according to any one of the preceding Claims wherein particle sizes are from 1 micron to 100 microns, preferably from 1 to 60 microns, most preferably from 1 to 20 microns.
8. The composition according to any one of the preceding Claims wherein particle sizes of the cyclodextrin are from 1 to 12 microns, and most preferably from 1 to 5 microns.
9. The composition according to any one of the preceding Claims further comprising adjunct odor controlling agents selected from the group consisting of zeolites, activated charcoal, sodium bicarbonate, antimicrobial agents, and antiperspirants.
10. The composition any one of the preceding Claims further comprising skin aids selected from the group consisting of skin protectants, emollients, and moisturizers.
11. A pre-formed wipe composition wherein the composition according to any one of the preceding Claims is deposited on a wipe which comprises a flexible dispensing means.
12. The composition according to any one of the preceding Claims delivered as a powder by a manually activated spray dispenser.
13. The use, in reducing body and/or vaginal odor, of an odor absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; and b. a powder carrier; wherein the composition is applied to occluded skin, a pelvic region, an external vagina, and or a panty-area.
14. The use, in reducing body and or vaginal odor and excess moisture, of an odor and moisture absorbing composition comprising: a. 0.1% to 25%, by weight of the composition, of uncomplexed cyclodextrin; b. 5% to 60%, by weight of the composition, of a highly effective moisture absorber; and c. a powder carrier; wherein the composition is applied to occluded skin, a pelvic region, an external vagina, and or a panty-area.
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002269471A CA2269471A1 (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing body odors and excess moisture |
| IL12957197A IL129571A0 (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing body odors and excess moisture |
| IDW990256D ID23973A (en) | 1996-10-28 | 1997-10-27 | COMPOSITION TO REDUCE EXCESSIVE BODY AND HUMIDITY HUMIDITY |
| JP52061298A JP2002515890A (en) | 1996-10-28 | 1997-10-27 | Composition for reducing body odor and excess moisture |
| AU49183/97A AU4918397A (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing body odors and excess moisture |
| BR9712449-4A BR9712449A (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing odors and excess moisture from bodies |
| EP97911917A EP0954276A1 (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing body odors and excess moisture |
| NO991895A NO991895L (en) | 1996-10-28 | 1999-04-21 | Mixtures to reduce body odors and excess moisture |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/736,838 | 1996-10-28 | ||
| US08/739,091 | 1996-10-28 | ||
| US08/739,091 US5885599A (en) | 1996-10-28 | 1996-10-28 | Methods and compositions for reducing body odors and excess moisture |
| US08/736,838 US5780020A (en) | 1996-10-28 | 1996-10-28 | Methods and compositions for reducing body odor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1998018439A1 true WO1998018439A1 (en) | 1998-05-07 |
| WO1998018439A9 WO1998018439A9 (en) | 1998-08-20 |
Family
ID=27113117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/019262 WO1998018439A1 (en) | 1996-10-28 | 1997-10-27 | Compositions for reducing body odors and excess moisture |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN1307467A (en) |
| AU (1) | AU4918397A (en) |
| CA (1) | CA2269471A1 (en) |
| CZ (1) | CZ147499A3 (en) |
| IL (1) | IL129571A0 (en) |
| NO (1) | NO991895L (en) |
| WO (1) | WO1998018439A1 (en) |
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044566A1 (en) * | 1998-03-02 | 1999-09-10 | The Procter & Gamble Company | Highly absorbent body powders |
| WO1999055813A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor control |
| WO1999055814A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor and wrinkle control |
| WO1999055815A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor control |
| WO2000035413A1 (en) * | 1998-12-15 | 2000-06-22 | The Procter & Gamble Company | Methods of absorbing body odors using silica containing body powders |
| US6110449A (en) * | 1999-06-14 | 2000-08-29 | The Procter & Gamble Company | Anhydrous antiperspirant cream compositions improved perfume longevity |
| US6123932A (en) * | 1999-06-14 | 2000-09-26 | The Procter & Gamble Company | Deodorant compositions containing cyclodextrin odor controlling agents |
| US6433243B1 (en) | 1999-02-26 | 2002-08-13 | Kimberly-Clark Worldwide, Inc. | Water permeable porous layer materials treated with surfactant-modified cyclodextrins |
| US6479150B1 (en) | 1999-02-26 | 2002-11-12 | Kimberly-Clark Worldwide, Inc. | Layer materials treated with surfactant-modified hydrophobic odor control agents |
| DE10123989A1 (en) * | 2001-05-17 | 2002-11-21 | Beiersdorf Ag | Use of salts(s) of trivalent or tetravalent metal ion with oligo- or polysaccharide(s) in composition for reducing production of and/or for removing sebum |
| JP2002543243A (en) * | 1999-04-29 | 2002-12-17 | ビーエーエスエフ アクチェンゲゼルシャフト | Superabsorbent polymer containing odor control compound |
| US6509284B1 (en) | 1999-02-26 | 2003-01-21 | Kimberly-Clark Worldwide, Inc. | Layer materials treated with surfacant-modified chelating agents |
| US6528013B1 (en) | 1998-04-27 | 2003-03-04 | The Procter & Gamble Company | Uncomplexed cyclodextrin compositions for odor and wrinkle control |
| DE10141682A1 (en) * | 2001-08-25 | 2003-03-06 | Beiersdorf Ag | Cyclodextrin is used in production of cosmetic and dermatological compositions to give improved filler distribution on the skin |
| DE10141683A1 (en) * | 2001-08-25 | 2003-03-06 | Beiersdorf Ag | Cyclodextrin is used in production of cosmetic and dermatological compositions to give improved inorganic pigment distribution on the skin |
| JP2003095906A (en) * | 2001-09-27 | 2003-04-03 | Lion Corp | Antiperspirant deodorant composition |
| US6623848B2 (en) | 1999-08-20 | 2003-09-23 | Stockhausen Gmbh & Co. Kg | Water-absorbing polymers having interstitial compounds, a process for their production, and their use |
| US6649155B1 (en) | 1999-05-03 | 2003-11-18 | The Procter & Gamble Company | Anti-dandruff and conditioning shampoos containing certain cationic polymers |
| US7029704B2 (en) | 2003-12-29 | 2006-04-18 | Woods Jr Clifford E | Anti-itch solution |
| US8147808B2 (en) | 2005-05-19 | 2012-04-03 | The Procter & Gamble Company | Consumer noticeable improvement in wetness protection using solid antiperspirant compositions |
| US8318806B2 (en) | 2007-10-03 | 2012-11-27 | Zorbx Inc. | Deodorizing composition and method of forming thereof |
| US8632755B2 (en) | 2005-05-19 | 2014-01-21 | The Procter & Gamble Company | Consumer noticeable improvement in wetness protection |
| US8895041B2 (en) | 2012-03-23 | 2014-11-25 | The Procter & Gamble Company | Compositions for delivering perfume to the skin |
| US9649386B2 (en) | 2007-03-01 | 2017-05-16 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
| WO2017100875A1 (en) * | 2015-12-17 | 2017-06-22 | L'oreal | Anhydrous antiperspirant composition in the form of a powder |
| US10323131B2 (en) | 2007-02-20 | 2019-06-18 | Cellresin Technologies, Llc | Combination of substituted cyclodextrin compound and activated carbon |
| WO2020076501A1 (en) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Stoma powder including skin health ingredients |
| US11090250B2 (en) | 2007-03-01 | 2021-08-17 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101502076B1 (en) * | 2014-07-11 | 2015-03-12 | 백영배 | Cosmetic composition for control body odor |
| CN107669586B (en) * | 2017-10-19 | 2021-04-27 | 北京天然风尚健康科技有限公司 | Pure natural underarm odor removing cream and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5578965A (en) * | 1978-12-11 | 1980-06-14 | Kokando Kk | Heating smell sendinggforth matter |
| US4382079A (en) * | 1977-10-25 | 1983-05-03 | Colgate/Palmolive | Bicarbonate containing stick deodorant |
| JPH03170415A (en) * | 1989-11-30 | 1991-07-24 | Sunstar Inc | Antiperspirant aerosol composition |
| WO1994022500A1 (en) * | 1993-03-31 | 1994-10-13 | The Procter & Gamble Company | Absorbent articles for odor control with positive scent signal |
| WO1994022501A1 (en) * | 1993-03-31 | 1994-10-13 | The Procter & Gamble Company | Articles containing small particle size cyclodextrin for odor control |
-
1997
- 1997-10-27 AU AU49183/97A patent/AU4918397A/en not_active Abandoned
- 1997-10-27 CN CN97199199A patent/CN1307467A/en active Pending
- 1997-10-27 CZ CZ991474A patent/CZ147499A3/en unknown
- 1997-10-27 IL IL12957197A patent/IL129571A0/en unknown
- 1997-10-27 WO PCT/US1997/019262 patent/WO1998018439A1/en not_active Application Discontinuation
- 1997-10-27 CA CA002269471A patent/CA2269471A1/en not_active Abandoned
-
1999
- 1999-04-21 NO NO991895A patent/NO991895L/en not_active Application Discontinuation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4382079A (en) * | 1977-10-25 | 1983-05-03 | Colgate/Palmolive | Bicarbonate containing stick deodorant |
| JPS5578965A (en) * | 1978-12-11 | 1980-06-14 | Kokando Kk | Heating smell sendinggforth matter |
| JPH03170415A (en) * | 1989-11-30 | 1991-07-24 | Sunstar Inc | Antiperspirant aerosol composition |
| WO1994022500A1 (en) * | 1993-03-31 | 1994-10-13 | The Procter & Gamble Company | Absorbent articles for odor control with positive scent signal |
| WO1994022501A1 (en) * | 1993-03-31 | 1994-10-13 | The Procter & Gamble Company | Articles containing small particle size cyclodextrin for odor control |
| US5429628A (en) * | 1993-03-31 | 1995-07-04 | The Procter & Gamble Company | Articles containing small particle size cyclodextrin for odor control |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE WPI Derwent World Patents Index; AN 8054056c, XP002055925, "COMPOSITION EMITTING FRAGRANCE ON HEATING- PREPARED BY ADSORBING LIQUID PERFUME IN INORGANIC POWDER, CONTACTING WITH CYCLODEXTRIN, ADMIXING WITH COMBUSTIBLE BASE" * |
| PATENT ABSTRACTS OF JAPAN vol. 015, no. 413 22 October 1991 (1991-10-22) * |
Cited By (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044566A1 (en) * | 1998-03-02 | 1999-09-10 | The Procter & Gamble Company | Highly absorbent body powders |
| WO1999055813A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor control |
| WO1999055814A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor and wrinkle control |
| WO1999055815A1 (en) * | 1998-04-27 | 1999-11-04 | The Procter & Gamble Company | Improved uncomplexed cyclodextrin compositions for odor control |
| US6528013B1 (en) | 1998-04-27 | 2003-03-04 | The Procter & Gamble Company | Uncomplexed cyclodextrin compositions for odor and wrinkle control |
| WO2000035413A1 (en) * | 1998-12-15 | 2000-06-22 | The Procter & Gamble Company | Methods of absorbing body odors using silica containing body powders |
| US6433243B1 (en) | 1999-02-26 | 2002-08-13 | Kimberly-Clark Worldwide, Inc. | Water permeable porous layer materials treated with surfactant-modified cyclodextrins |
| US6479150B1 (en) | 1999-02-26 | 2002-11-12 | Kimberly-Clark Worldwide, Inc. | Layer materials treated with surfactant-modified hydrophobic odor control agents |
| US6509284B1 (en) | 1999-02-26 | 2003-01-21 | Kimberly-Clark Worldwide, Inc. | Layer materials treated with surfacant-modified chelating agents |
| JP2002543243A (en) * | 1999-04-29 | 2002-12-17 | ビーエーエスエフ アクチェンゲゼルシャフト | Superabsorbent polymer containing odor control compound |
| JP4933696B2 (en) * | 1999-04-29 | 2012-05-16 | ビーエーエスエフ ソシエタス・ヨーロピア | Superabsorbent polymers containing odor control compounds |
| US6649155B1 (en) | 1999-05-03 | 2003-11-18 | The Procter & Gamble Company | Anti-dandruff and conditioning shampoos containing certain cationic polymers |
| WO2000076472A1 (en) * | 1999-06-14 | 2000-12-21 | The Procter & Gamble Company | Anhydrous antiperspirant cream compositions having improved perfume longevity |
| US6123932A (en) * | 1999-06-14 | 2000-09-26 | The Procter & Gamble Company | Deodorant compositions containing cyclodextrin odor controlling agents |
| US6110449A (en) * | 1999-06-14 | 2000-08-29 | The Procter & Gamble Company | Anhydrous antiperspirant cream compositions improved perfume longevity |
| US6623848B2 (en) | 1999-08-20 | 2003-09-23 | Stockhausen Gmbh & Co. Kg | Water-absorbing polymers having interstitial compounds, a process for their production, and their use |
| DE10123989A1 (en) * | 2001-05-17 | 2002-11-21 | Beiersdorf Ag | Use of salts(s) of trivalent or tetravalent metal ion with oligo- or polysaccharide(s) in composition for reducing production of and/or for removing sebum |
| DE10141682A1 (en) * | 2001-08-25 | 2003-03-06 | Beiersdorf Ag | Cyclodextrin is used in production of cosmetic and dermatological compositions to give improved filler distribution on the skin |
| DE10141683A1 (en) * | 2001-08-25 | 2003-03-06 | Beiersdorf Ag | Cyclodextrin is used in production of cosmetic and dermatological compositions to give improved inorganic pigment distribution on the skin |
| JP2003095906A (en) * | 2001-09-27 | 2003-04-03 | Lion Corp | Antiperspirant deodorant composition |
| US7029704B2 (en) | 2003-12-29 | 2006-04-18 | Woods Jr Clifford E | Anti-itch solution |
| US8147808B2 (en) | 2005-05-19 | 2012-04-03 | The Procter & Gamble Company | Consumer noticeable improvement in wetness protection using solid antiperspirant compositions |
| US8632755B2 (en) | 2005-05-19 | 2014-01-21 | The Procter & Gamble Company | Consumer noticeable improvement in wetness protection |
| US10323131B2 (en) | 2007-02-20 | 2019-06-18 | Cellresin Technologies, Llc | Combination of substituted cyclodextrin compound and activated carbon |
| US10149910B2 (en) | 2007-03-01 | 2018-12-11 | The Procter & Gamble Plaza | Compositions and/or articles comprising cyclodextrin complexing material |
| US9649386B2 (en) | 2007-03-01 | 2017-05-16 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
| US9649387B2 (en) | 2007-03-01 | 2017-05-16 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
| US11090250B2 (en) | 2007-03-01 | 2021-08-17 | The Procter & Gamble Company | Compositions and/or articles comprising cyclodextrin complexing material |
| US8318806B2 (en) | 2007-10-03 | 2012-11-27 | Zorbx Inc. | Deodorizing composition and method of forming thereof |
| US9161899B2 (en) | 2012-03-23 | 2015-10-20 | The Procter & Gamble Company | Compositions for delivering perfume to the skin |
| US9364417B2 (en) | 2012-03-23 | 2016-06-14 | The Procter & Gamble Company | Compositions for delivering perfume to the skin |
| US8895041B2 (en) | 2012-03-23 | 2014-11-25 | The Procter & Gamble Company | Compositions for delivering perfume to the skin |
| WO2017100875A1 (en) * | 2015-12-17 | 2017-06-22 | L'oreal | Anhydrous antiperspirant composition in the form of a powder |
| WO2020076501A1 (en) * | 2018-10-10 | 2020-04-16 | Hollister Incorporated | Stoma powder including skin health ingredients |
| CN113038935A (en) * | 2018-10-10 | 2021-06-25 | 霍利斯特公司 | Ostomy powder containing skin healing ingredients |
| AU2019356464B2 (en) * | 2018-10-10 | 2024-08-22 | Hollister Incorporated | Stoma powder including skin health ingredients |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4918397A (en) | 1998-05-22 |
| CN1307467A (en) | 2001-08-08 |
| NO991895L (en) | 1999-06-28 |
| IL129571A0 (en) | 2000-02-29 |
| CZ147499A3 (en) | 1999-09-15 |
| NO991895D0 (en) | 1999-04-21 |
| CA2269471A1 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5885599A (en) | Methods and compositions for reducing body odors and excess moisture | |
| US5780020A (en) | Methods and compositions for reducing body odor | |
| WO1998018439A1 (en) | Compositions for reducing body odors and excess moisture | |
| WO1998018439A9 (en) | Compositions for reducing body odors and excess moisture | |
| US6004584A (en) | Highly absorbent body powders | |
| US5861143A (en) | Methods for reducing body odors and excess moisture | |
| US5861146A (en) | Method for reducing body odor | |
| US5861144A (en) | Perfumed compositions for reducing body odors and excess moisture | |
| CA2293663A1 (en) | Perfumed compositions and methods for reducing body odors and excess moisture | |
| AU721891B2 (en) | Methods and compositions for reducing body odor | |
| US5879666A (en) | Methods and compositions for reducing body odor | |
| AU731790B2 (en) | Compositions for reducing odor on skin | |
| US5897855A (en) | Methods and compositions for reducing body odor | |
| WO2000035413A1 (en) | Methods of absorbing body odors using silica containing body powders | |
| US5897856A (en) | Methods and compositions for reducing body odor | |
| US5911976A (en) | Compositions for reducing body odor | |
| KR20000052842A (en) | Compositions for reducing body odors and excess moisture | |
| CN1261786A (en) | Ferfumed compositions and method for reducing body odors and excess moisture | |
| MXPA99003982A (en) | Compositions for reducing body odors and excess moisture | |
| HUP9904072A2 (en) | Preparations to reduce body odor and excessive sweating | |
| MXPA99011488A (en) | Perfumed compositions and methods for reducing body odors and excess moisture | |
| CZ441499A3 (en) | Body odors absorbing preparations containing cyclodextrin, perfume composition and powder carrier and method of their application | |
| MXPA99003876A (en) | Compositions for reducing odor on skin | |
| JP2002509525A (en) | Skin odor reducing composition | |
| MXPA99003918A (en) | Methods and compositions for reducing body odor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 97199199.5 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| COP | Corrected version of pamphlet |
Free format text: PAGES 10-13, DESCRIPTION, REPLACED BY NEW PAGES 10-13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2269471 Country of ref document: CA Ref document number: 2269471 Country of ref document: CA Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1999/00891 Country of ref document: TR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997911917 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PV1999-1474 Country of ref document: CZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1019997003676 Country of ref document: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/003982 Country of ref document: MX |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: PV1999-1474 Country of ref document: CZ |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997911917 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 1019997003676 Country of ref document: KR |
|
| WWR | Wipo information: refused in national office |
Ref document number: PV1999-1474 Country of ref document: CZ |
|
| WWR | Wipo information: refused in national office |
Ref document number: 1019997003676 Country of ref document: KR |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997911917 Country of ref document: EP |